All articles by Rachel Cordery

Rachel Cordery

Deals interview with Mike Preston of Cleary Gottlieb: Oncology is driving healthcare M&As

Pharmaceutical Technology spoke to Mike Preston at top-ten legal adviser Cleary Gottlieb Steen & Hamilton to gain greater insight into the latest trends around M&A in the healthcare industry

Myovant reports uterine fibroid combination therapy results

UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase III study of relugolix combination therapy.